FDA Issues Draft Guidance on Off-Label Use Information Dissemination

Share on Facebook
The U.S. Food and Drug Administration issued a draft guidance for manufacturers regarding distributing information about off-label uses for their products.

Read the full article on Becker's Hospital Review.

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


New from Becker's ASC Review

ASC inventory management innovation: DePuy Synthes Select's Steve Clareen discusses

Read Now